Gerry Murphy, PhD
Expertise and Zeal: CMC Development Leadership, QC Management and Expertise for Large and Small Molecules from IND to BLA/MAA and Commercial Space in small and large biopharmaceutical companies.
Gerry has over 29 years experience in development, manufacturing, CMC and QA/QC of therapeutic proteins and vaccines in both small and large biopharmaceutical companies in the UK, Canada and Ireland. Experienced in leading international, multi-functional groups to address global regulatory CMC expectations throughout the product life cycle. Most recently Gerry was Head of International Quality Control at NPS Pharma International. Gerry has previously held senior QC leadership and technical positions at Elan Pharma International, Janssen Alzheimer’s Immunotherapy (a J&J company), Wyeth BioPharma, Biomira Inc. and Amersham International. In recent years, Gerry worked as a Consultant CMC lead for managing multiple CMC projects from the cell line development stage through to clinical material manufacture and supply chain activities.
Gerry earned his Ph.D. in Biochemistry and his B.A. (Mod) in Biochemistry, from Trinity College Dublin, Ireland.